The role of metabolic reprogramming in oocyte development: research progress and prospects

• by Yawen Li, Yu Liu, Jing Jin

• May 21, 2026

Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

• by Asad Omarion, Yaman Ayasa, Zainab Omarion, Batoul Jayouse, Hazem Ayesh

• July 20, 2026

Combined metabolic-reproductive association and predictive value of AMH and TyG index in PCOS: a single-center retrospective study

• by Yu Chen, Xinyan Shi, Lin Ma, Yujie Hu, Mei Wang, Lei Shu

• July 8, 2026

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts

• by Kerri Miller

• May 13, 2026

• 4 min